Biological aging is characterized by a chronic low-grade inflammation level. This chronic phenomenon has been named "inflamm-aging" and is a highly significant risk factor for morbidity and mortality in the older persons. The most common theories of inflamm-aging include redox stress, mitochondrial dysfunction, glycation, deregulation of the immune system, hormonal changes, epigenetic modifications, and dysfunction telomere attrition. Inflamm-aging plays a role in the initiation and progression of age-related diseases such as type II diabetes, Alzheimer's disease, cardiovascular disease, frailty, sarcopenia, osteoporosis, and cancer. This review will cover the identification of pathways that control age-related inflammation across multiple systems and its potential causal role in contributing to adverse health outcomes.
Biological aging results from an accumulation of genetic and epigenetic modifications that lead to progressive cell deterioration, impaired tissue function, a vulnerability to stressors, and decreased physiological reserves yielding a limited capacity to maintain homeostasis (1) . While a single mechanism for the cause and progression of biological aging has not been established, among the most common theories include redox stress, mitochondrial dysfunction, glycation, deregulation of the immune system, hormonal changes, epigenetic modifications, and dysfunction telomere attrition. Environment can also have a role in biological aging by disrupting the homeostatic balance. Indeed, environmental pollutants such as air pollution may lead to biological mechanisms (inflammatory phenomena, oxidative stress, metabolic disorders, and genetic/epigenetic modifications) also involved in aging. Despite these widely accepted models, however, the etiology of biological aging at the cellular and molecular levels remains largely undefined. Previous studies have suggested that chronic inflammation contributes to accelerate biological aging (2) . While the immune response characteristic of acute inflammation dampens within days, chronic inflammation is characterized by elevated levels of proinflammatory cytokines in response to physiological and environmental stressors that essentially arrest the immune system in a state of low-level activation (3) . The chronically active immune system associated with advancing age, has been termed "inflamm-aging" (4) . Although definitive mechanisms are yet to be identified, the proinflammatory phenotype of cells, coupled with the up-regulation of the inflammatory response with increasing age, has been found to play a role in the initiation and progression of agerelated diseases such as type II diabetes, Alzheimer's disease, cardiovascular disease, frailty, sarcopenia, osteoporosis, and cancer. This review will cover the identification of pathways that control age-related inflammation across multiple systems and its potential causal role in contributing to adverse health outcomes. In order to do a systematic review on the inflammation, the last published articles on the topics have been examined. Thus, we have been able to collect updated data.
Definition of Inflammation
Subsequent to trauma or infection, the inflammatory response is initiated at a local, cellular level. A number of cellular mediators such as macrophages and monocytes are activated. These cells release cytokines like tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) which act as molecular mediators and are responsible for the progression of the response to a systemic level encompassing multiple organs. The inflammatory cascade is designed to destroy microbial pathogens, initiate tissue repair processes, and promote a return to physiological homeostasis (5) . At an acute level, this process is marked by easily discernible heat, swelling, redness, and pain. However, in terms of aging and age-related diseases, the inflammation response is a chronic (inflamm-aging), low level, subclinical process mediated by the same effectors, but differing significantly in degree (6) .
Inflamm-aging has been well characterized in numerous epidemiological studies. Levels of inflammatory mediators typically increase with age even in the absence of acute infection or other physiologic stress (7) . While levels are still in the subacute range, this chronic inflammation underlies many aging-related conditions (8) .
One factor that can distinguish acute and chronic inflammation is the relative strength of anti-inflammatory responses. Anti-inflammatory responses are a critical negative regulatory component of acute inflammation. The nature and extent to which these responses occur during inflamm-aging is less understood. Nonetheless, anti-inflammatory responses do occur in inflammaging and they can at least partially counteract or compensate for chronic inflammatory processes (4).
Mechanisms of Inflamm-Aging
Multiple mechanisms contribute to age-related inflammation ( Figure 1 ). The redox stress hypothesis of aging is based on agerelated alterations in cellular redox balance accompanied by age-related deregulation of the immune system. Other processes (hormonal changes, epigenetic modifications, …) also contribute to elevated inflammation in aging. Finally, some as telomere shortening may be a consequence of inflammation.
The Redox Stress Hypothesis of Aging
Currently, oxidative stress and impaired antioxidant defense mechanisms are believed to be key contributors to the biologic aging process. Oxidative stress develops as a consequence of excessive generation of reactive oxygen species (ROS), by enzymes such as NADPH oxidase, uncoupled nitric oxide synthase, and xanthine oxidase, by the mitochondrial electron transport chain, and as a result of reduced antioxidant capacity (9) . There is substantial evidence supporting the involvement of oxidative stress in the genesis of damage within the aging process. Interestingly, evidence provides a close link between oxidation and inflammation, since excessive or uncontrolled free radical production can induce an inflammatory response and free radicals are inflammation effectors (10) .
Glycation
Advanced glycation end-products (AGEs) were first identified in cooked food as end-products from a nonenzymatic reaction between sugars and proteins called the Maillard reaction (11) . Since the discovery that this reaction also occurs in vivo, it has been suggested that AGEs may play a role in the pathophysiology of several different diseases. Glycation is one of the endogenous aging mechanisms which occurs spontaneously during time but also, in a pathological manner, during diabetes, renal failure, and inflammation (glycoxidation) (12) . AGEs accumulate in aging tissues and organs during rheumatoid arthritis and Alzheimer disease. These aging toxins are especially involved in cell alteration during diabetes mellitus (glycotoxin) and renal failure (uremic toxin). AGEs participate to the endothelial dysfunction leading to diabetic macro but also microangiopathy. AGEs binding to cell receptors are critical steps in the deleterious consequences of AGE excess. AGE-receptor activation altered cell and organ functions mainly by a proinflammatory and profibrosis factors cell response leading to aging. The receptor for AGEs (RAGE) is the best-characterized cell surface molecule that recognizes AGEs. The key to RAGE biology is its ability to bind and transduce the molecular effects of multiple inflammatory ligands such as AGEs but also S100 calgranulins and HMGB.1. RAGE regulates a number of cell processes of crucial importance such as inflammation, apoptosis, ROS signaling, proliferation, autophagy, and, more recently, aging (13, 14) . The role of dietary AGEs and their interaction with the receptor RAGE during aging has been recently demonstrated (15) . In a mice model, it has been shown that a 9-month dietary exposure to carboxymethyl-lysine (CML, the AGE with the highest affinity for RAGE) accelerates endothelial dysfunction and arterial aging in vivo (angio-MRI) and ex-vivo (Mulvani Myograph) in a RAGE dependent manner.
Mitochondrial Dysfunction in Aging
Mitochondria are intracellular structures present in almost all mammalian cells. Their primary role is of adenosine triphosphaste (ATP) production through oxidative phosphorylation. The mitochondrial free radical theory of aging is based on oxidative damage to mitochondrial DNA (mtDNA) due to overproduction of ROS. Somatic mtDNA mutations have been reported in normal human aging, particularly in skeletal muscle and neurons, but also in replicative tissue, and somatic mtDNA mutations are also well-described in age-associated neurodegenerative diseases such as Alzheimer's disease (16) . In addition, apoptosis is a highly regulated process that leads to cell death without stimulation of the inflammation response and damage to surrounding tissue. With age, mismanagement of apoptosis due to mitochondrial dysfunction results in increased inflammation and tissue injury (17) .
Age-Related Deregulation of the Immune System (Immunosenescence)
Both the innate and the adaptive arm of the immune system undergo marked changes with age and contribute to the process of immunosenescence (18) . With age, functioning of the adaptive immune system generally declines, whereas innate immune mechanisms generally become more active. Immunosenescence is characterized by a thymic involution leading to a steady decline in the production of naïve T-cells, a narrowing of the T-cell repertoire and a chronic low degree of inflammation as evidenced by increased serum levels of inflammatory cytokines such as IL-6, TNF-α, and acute phase proteins (19) .
Chronic Infections Promote Inflamm-Aging
Chronic infections promote inflamm-aging and immunosenescence; cytomegalovirus (CMV) promotes age-like immune changes (20) and CMV reactivation has been associated with increased levels of IL-6 and TNF-α and premature mortality (21) . Other chronic infectious diseases such as hepatitis C virus (HCV) and human immunodeficiency virus (HIV) may also have a role in inflamm-aging (22) . With effective antiretroviral therapy, the life expectancy of HIV patients has significantly improved and a link between chronic infection, immune dysregulation, and age-related comorbidities has become evident (23) . Microbial communities in the mouth have been shown to cause infectious diseases such as gingivitis and periodontitis (24) , and other chronic or systemic diseases (25) .
Hormonal Changes With Aging
The endocrine system also experiences age-related declines in function most notably affecting sex steroid production (7). Cortisol production is increased due to over-stimulation of the hypothalamic-pituitary-adrenal axis (26) . Chronic overstimulation of the axis leads to immune dysregulation and contributes to immunosenescence (27) . On the contrary, levels of growth hormone (GH), dehydroepiandrosterone (DHEA) and its circulating form DHEA sulfate (DHEAS) decrease with age (28) . Decreased levels of DHEA and GH likely play also a role in immunosenescence. Both DHEA and GH enhance the proliferation and activity of cellular mediators of immunity and DHEA reduces inflammatory cytokine production (29) . Reduction in levels of these hormones and increasing levels of cortisol with age would therefore lead to increased inflammation (29) . Sex hormones also modulate the production of inflammatory cytokines. Studies indicate that IL-6 gene transcription and secretion are inhibited by both estrogen and androgen (30) . As levels of these steroid hormones decrease with age, levels of inflammatory cytokines are increased contributing to chronic inflammation.
Proinflammatory Lipid Signaling and Aging
Aging is characterized by increases in fat cell number, fat cell size, or a combination of the two. Senescent cells accumulate to especially high levels in adipose tissue, particularly the visceral fat (31) . Fat is another rich source of inflammatory cytokines and major changes in fat distribution and lipid composition and function may have profound clinical consequences linked to several age-related disorders (32) . There is evidence that low-grade inflammation within the adipose tissue results in the dysregulation of adipocytokine production (33) . The adipose tissue is infiltrated by inflamed macrophages that release TNF-α (34) and IL-6 (35), thus linking inflammation and insulin resistance. Moreover, recent studies have been highlighting the positive association between obesity and inflammatory markers, mainly CRP protein in women (36) , but also other inflammatory markers, both in women and men (37) .
Diet and Inflammation
Diets that promote inflammation are high in refined starches, sugar, saturated, and trans-fats, and low in omega-3 fatty acids, natural antioxidants and fiber from fruits, vegetables, and whole grains (38) . For example, women in the Nurses' Health Study who ate a "Westernized" diet (high in red and processed meats, sweets, desserts, French fries, and refined grains) had higher CRP and IL-6 than those with the "prudent" pattern, characterized by higher intakes of fruit, vegetables, legumes, fish, poultry, and whole grains (39) . Further work from the Nurses' Health Study clearly linked transfatty acid consumption with higher inflammation; for example, CRP was 73% higher in women in the highest quintile of consumption compared with those in the lowest quintile, and IL-6 levels were 17% higher in the highest compared to the lowest quintiles (40) .
The association between trans-fat consumption and inflammation is a reliable finding across a number of controlled trials and observational studies (41) .
Role of Renin-Angiotensin System in Inflammation
The renin-angiotensin system (RAS) is classically considered as the major regulator of fluid homeostasis and blood pressure. Despite of the effects in the cardio-renal system, the chronic blockade of RAS has been related to an improvement of the inflammatory process, an increase in life span and a reduction in the severity of some autoimmune processes (42) . Indeed, the last two decades of research has provided consistent evidences that RAS is one of most important modulators of inflammatory diseases and the physiological aging. RAS activation is classically related to an increase in the inflammatory status characterized by the induction of the expression of several cytokines and chemokines, transcription factors and cell adhesion molecules (43) .
Epigenetic Mechanisms
Aging is accompanied by changes in chromatin (eg, DNA methylation and histone modifications) and changes to coding and noncoding RNA profiles (44) . Some of these epigenetic changes can be delayed by environmental factors (eg, air pollution) known to influence aging (45) . Inflamm-aging and oxidative stress and play an important role in epigenetic modifications of cytokines expression, oncogenes, and tumor suppressor genes (eg, p16 or p53), thereby setting up a ground for chronic inflammatory diseases and carcinogenesis (46) .
Inflammation in Homeostatic Remodeling
Chronic inflammation is an adaptive mechanisms generally which leads to tissue degeneration but is also part of normal tissue remodeling (47) . An example to illustrate this paradox is the centenarians. Indeed, the centenarians often have biologic signs of systemic inflammation (eg, high plasma levels of IL-6 and IL-8) as well as decreased antioxidant defenses and show a hypercoagulability state characterized by higher plasma level of important factors involved in the hemostasis balance. However, centenarians delay the onset of chronic age-related diseases such as cardiovascular disease, type II diabetes, and cancer, suggesting that inflammaging and hypercoagulable state are compatible with health and longevity. These paradoxes suggest that determinants other than biologic levels of proinflammatory markers might be important factors of whether an individual's inflammatory status is adaptive or pathogenic (48) .
Senescent Cells as a Source of Chronic Inflammation
Inflamm-aging might be due to cellular senescence. Senescence is a cellular response to damage and stress. The senescence response prevents cancer by suppressing the proliferation of cells with a compromised genome and contributes to optimal wound healing in normal tissues (48) . Cellular senescence is accompanied by a striking increase in the secreted levels of more 40 factors involved in intercellular signaling (49) . This phenotype has been termed the "senescenceassociated secretory phenotype," or SASP (50) . The SASP has many of the paracrine effects one would expect from a pro-inflammatory stimulus, which can be deleterious if left unchecked. Senescent cells accumulate with age in many tissues and are prominent at sites of many age-related pathologies.
How Mechanisms Between Inflammation and Telomere Dysfunction Accelerates Aging
Telomere shortening with increasing age is a part of the normal aging process. If shortened telomeric DNA is not repaired by the enzyme telomerase, cells with critically short telomere length become senescent. However, factors such as inflammation, oxidative stress, and other genotoxic stressors also increase the rate of telomere attrition, leading to telomere dysfunction-mediated cellular senescence and accelerating the aging process (51) . Telomere length also associates with inflammatory markers, further underscoring the role of inflammation in telomere shortening and aging (52) .
Inflammation Role in Contributing to Adverse Health Outcomes With Aging
The major chronic diseases associated with inflammation and aging are cardiovascular diseases, cancer, type 2 diabetes, sarcopenia, osteoporosis, Alzheimer's disease, and frailty, share a common inflammatory pathogenesis (Figure 2 ). However, it always exists a quandary in the theory of inflamm-aging: inflammation leads chronic diseases or chronic diseases is the source of inflammatory process. It seems that the possibility of a bidirectional relationship between inflammation and pathology rather than (as in the present form) privileging a one-way direction is an interesting hypothesis.
Cardiovascular Diseases
Multiple independent pathways of evidence now identify inflammation as a key regulatory process that links multiple risk factors for atherosclerosis and its complications (53) . TNF-α activates a proinflammatory gene expression profile in endothelial cells that promotes adherence of monocytes and their migration. Considerable evidences support also that essential hypertension is a condition of inflammaging (54) . Inflammation can enhance the proliferation of smooth muscle cells and play a role in vascular remodeling (55) . Finally, an analysis from the Framingham Heart Study reports well-established associations between inflammation and prevalence of cardiovascular conditions that predispose to arterial fibrillation (56). Conen and colleagues (57) provide evidence that inflammation, which is measured by plasma levels of CRP and fibrinogen, is significantly associated with arterial fibrillation in a population where cardiovascular risk factors were controlled and without a history of cardiovascular disease.
Cancer
Several studies have suggested a strong association between inflammation and cancer (58, 59) . ROS are involved in carcinogenesis, not only damaging DNA, but also modifying cancer-related proteins and regulating transcription (60) . Furthermore, several evidences indicate that even in tumors not directly linked to pathogens, the microenvironment is characterized by the presence of an inflammation, fuelled primarily by leukocytes and by hypoxic conditions (61, 62) . In this inflammation status, IL-6 plays a major role. Indeed, overproduction of IL-6 contributes, through its roles as a growth factor or an anti-apoptotic factor, to the development of malignant diseases. TNF-α has been also implicated in the pathogenesis of cancer because it triggers DNA damage, angiogenesis, invasion, and metastasis and in experimental models, most evidence supports the potential enhancement of neoplasia by anti-TNF-α (63). Finally, cyclooxygenase (COX) is a key enzyme in the formation of inflammatory mediator prostaglandins, and an inducible isoform of COX, COX-2, has been implicated in cancer (64, 65) .
Type II Diabetes
Up-regulated levels of proinflammatory cytokines and acute-phase reactants of inflammation are involved in the pathogenesis of type II diabetes (66, 67) . Among individuals diagnosed with type II diabetes, epidemiological, and mechanistic studies have shown that IL-6, TNF-α, and CRP are positively correlated with insulin resistance, BMI/waist circumference, circulating triglycerides, and atherosclerotic processes (68) .
Osteoporosis
Inflamm-aging is a mechanism involved for the development of lower bone mass (69, 70) . A long list of these cytokines has been shown capable of stimulating osteoclastic bone resorption (IL-1, TNF-α, IL-6, IL-11, IL-15, and IL-17). For example, IL-6 promotes osteoclast differentiation and activation (71) . TNF-α is implicated in tumourinduced bone resorption and nontumor-induced osteopenia (72) .
Sarcopenia
It has been demonstrated that inflamm-aging is considered as significant contributor to age-related muscle wasting process (73, 74) . Some studies reported that high IL-6 and CRP levels are associated with increased risk of muscle mass and strength loss (75, 76) . Moreover, some studies proved that high levels of TNF-α can increase muscle catabolism (77) . In addition, it seems that proinflammatory cytokines may antagonize the anabolic effect of IGF-1, because of the development of GH resistance, which decreases both circulating and muscle IGF-1 (77) . The relation between inflammation, muscle strength and muscle mass seems to have an explanation based on the effect of inflammation on the homeostatic balance at the muscle level between protein synthesis and catabolism (78) . Histological studies have shown that high values of serum CRP seem to be related with reduced protein synthesis and increased protein catabolism (79) . Studies have reported that inflammation can impair insulin action, modify hormone secretion and hormone receptor transduction, impair endothelial function and energy regulation, and contribute to microvascular changes in the vascular system (80, 81) , which may contribute to muscle weakness, lack of endurance, ineffective cell metabolism and energy production, and impaired central nervous system control of motor movements.
Frailty
Frailty pathogenesis can be at least partially explained by increased levels of inflammatory mediators. A number of studies have explored inflammation and frailty (82, 83) . IL-6 is consistently associated with frailty in both cross-sectional (84) and prospective studies (83) , while evidence for CRP and TNF-α is mixed. For CRP, associations with prevalent and incident frailty were found in the Cardiovascular Health Study (85) , and Hubbard and colleagues (86) and Wu and colleagues (87) reported association with prevalent frailty. However, no association with incident frailty is found in the Women's Health Initiative-Observational Study (83) or with prevalent frailty in the InCHIANTI study (88) . For TNF-α, Serviddio and colleagues (89) and Hubbard and colleagues (86) found an association with prevalent frailty, while no association was seen in the INCHIANTI study (88) .
Alzheimer's Disease and Dementia
It has been hypothesized that inflammation is a precursor to the development of neurofibrillary tangles, amyloid plaques and neurodegeneration, hallmarks of Alzheimer's disease (90) . Moreover, IL-6 is involved in other pathophysiological processes of the nervous system such as demyelination, which could contribute to white matter changes, and neurodegeneration (91) . High levels of serum CRP and IL-6 and plasma TNF-α have been associated with decreased total brain volume (92) . High serum CRP has also been associated with markers indicative of decreased neuronal function and decreased brain metabolism, suggesting CRP may play a role in cognitive decline or dementia (93) . Finally, higher levels of IL-6 have also been shown to be related to decreased hippocampal volume (94) .
Another way that inflammation could contribute to the underlying etiologic process of Alzheimer's disease through the development of other dementia risk factors. For example, elevated IL-6 affects lipid metabolism and triglyceride production, and stimulates the hypothalamic-pituitary-adrenal axis, which is associated with central obesity, hypertension, and insulin resistance; all of these factors are associated with an increased risk of dementia. Higher levels of inflammation are also associated with cardiovascular disease, which is a risk factor for dementia.
Finally, infection or systemic inflammation may also underlie an association between inflammation and dementia (95) . It has been hypothesized that microglia are changed in older adults due to infection and acute inflammatory response (95) . These changes in the microglia associated with aging are quite pernicious, because rather than triggering a protective or anti-inflammatory response in the brain, a heightened inflammatory response is initiated in the brain after infection or systemic inflammation occurs, which contributes to increased neurodegeneration (95) .
The Paradoxical Beneficial Role of Inflammation
The paradoxical beneficial role of inflammation is not low-grade, but high grade and typically acute. Indeed, inflammation is necessary to manage with damaging agents and is crucial for survival, particularly to cope with acute inflammations (96) . Inflammation can be beneficial as an acute, transient immune response to harmful conditions such as traumatic tissue injury or an invading pathogen. This response also facilitates the repair, turnover, and adaptation of many tissues. However, acute inflammatory responses to pathogen-associated molecular patterns may be impaired during aging, leading to increased susceptibility to infection (48) . The inflammatory response is a natural defense mechanism that is triggered whenever body tissues are damaged. Inflammation occurs in response to physical trauma, intense heat and irritating chemicals, as well as to infection by viruses and bacteria. The inflammatory response prevents the spread of damaging agents to nearby tissues, disposes of cell debris and pathogens and sets the stage for the repair process.
Inflammation helps to maintain homeostasis in the body by coordinating immune function, including T-cell mediation to identify and eliminate cancer cells. As seen previously, in chronic inflammatory diseases, ROS cause tissue damage. However, ROS can also act as modulators of inflammation, helping to resolve this tissue damages (97) . In fact, inflammation is not as harmful as it has been assumed. It is natural defense system in the human body working against infectious diseases as well as cancers. Anti-inflammatory therapy could be harmful rather than beneficial for health. Excessive antiinflammatory therapy could disrupt the maintenance of necessary metabolic balance between inflammatory and anti-inflammatory processes. Indeed, anti-inflammatory therapy could impair immune system and increase likelihood of developing cancers by means of decreased immune protection and direct cell and DNA damage.
Some Suggestions to Reduce Inflamm-Aging and Age-Related Pathologies
First, drugs that suppress senescent cells, or eliminate their SASP, would allow to reduce chronic inflammation (98) . Second, if immunosenescence is an important mechanism of inflamm-aging, thymic replacement or other strategies, for example, local and/or systemic neutralization of proinflammatory cytokines such as IL-6, effective vaccine against CMV and HIV, may be important to increase adaptive immune function and to decrease the decline of the immune system (48) . Finally, lifestyle interventions such as physical activity or nutrition can help to minimize inflamm-aging and age-related pathologies.
Conclusion
Ideally, inflammation should clear out the infection and then subside to allow normal tissue to be rebuilt, according to a physiological beneficial process. However, inflammation, becoming chronic, can cause in the majority of older people a low-grade inflammation, recognized as one of the key risk factors for mortality. Moreover, there is strong evidence that the development of age-related multifactorial conditions such as type II diabetes, Alzheimer's disease, cardiovascular disease, frailty, sarcopenia, osteoporosis, and cancer are associated to low-grade elevations in levels of circulating inflammatory mediators. Focusing future work on interventions that address dysregulated immune control in the aging host rather than treating symptoms of disease or attempting to block the effects of the inflammatory mediators themselves, will offer improved therapeutic opportunities. The most important aspect will be to preserve of the overall homeostatic balance.
